Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01429285 · ClinicalTrials.gov registry record · Phase 4

Safety and Efficacy of Intravenous Hydromorphone in Elderly Emergency Department Patients With Acute Severe Pain

A Phase 4 study of Pain, sponsored by Montefiore Medical Center.

Completed
Registry status
Phase 4
Development phase
350
Enrollment target
1
Study location

NCT01429285 is a Phase 4 study of Pain that has completed, run by Montefiore Medical Center. The registered enrollment target is 350 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (16% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01429285, a Phase 4 study of Pain, has completed, sponsored by Montefiore Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

The hydromorphone protocol is more effective than usual care in Emergency Department (ED) patients age 65 years and older in terms of proportion who choose to forgo additional pain medication within 60 minutes post-baseline in the two groups.

Conditions Studied

Interventions

  • DRUG Hydromorphone
  • DRUG Usual care

Study Locations (1)

New York

  • Montefiore Emergency Department - The Bronx

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2009-07
Est. Completion 2012-06
Phase Phase 4

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT01429285

The ClinicalTrials.gov registry entry for NCT01429285 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 303-participant average among 374 other Pain trials with a reported enrollment target (16% higher). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Hydromorphone is the first listed.

NCT01429285 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01429285 about?

NCT01429285 is a clinical study titled "Safety and Efficacy of Intravenous Hydromorphone in Elderly Emergency Department Patients With Acute Severe Pain". The hydromorphone protocol is more effective than usual care in Emergency Department (ED) patients age 65 years and older in terms of proportion who choose to forgo additional pain medication within 60 minutes post-baseline in the two groups.

What is the current status of trial NCT01429285?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2009-07. Estimated completion is 2012-06.

What conditions does trial NCT01429285 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01429285?

The interventions under investigation include: Hydromorphone (DRUG), Usual care (DRUG).

Who is sponsoring clinical trial NCT01429285?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01429285 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.